Reports
Sale
Global Pain Management Devices Market Size, Share, Growth: By Type: Neurostimulation Devices, Ablation Devices, Analgesic Infusion Pump; By Mode of Purchase: OTC, Prescription Based; By Application: Neuropathic Pain, Cancer Pain, Facial Pain and Migraine, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Pain Management Devices Market Outlook
The global pain management market value was USD 5.22 billion in 2023, driven by the increasing prevalence of chronic pain conditions across the globe. The market size is anticipated to grow at a CAGR of 8.7% during the forecast period of 2024-2032 to achieve a value of USD 11.05 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Demand for Neurostimulation Devices to Augment the Pain Management Devices Market Growth
Based on type, the neurostimulation devices sector accounts for a significant share in the pain management devices market. This can be attributed to the rise in the number of diabetic patients. Further, the rise in geriatric population can be linked to the growth. The rising consumer disposable income, particularly in developing nations, is significantly contributing to the growth of the segment.
The Asia Pacific to Provide Enhanced Growth Opportunities to the Pain Management Devices Market
Region-wise, the Asia Pacific is expected to witness a robust growth over the forecast period owing to the rise in chronic diseases, such as diabetes and cancer. Furthermore, the presence of large population in countries like India and China is expected to significantly contribute to the market growth in the forecast period.
Market Segmentation
Pain management is a branch of medicine that uses an interdisciplinary approach for easing the suffering and improving the quality of life of those living with chronic pain. Pain sometimes resolves quickly once the underlying trauma or pathology has healed, and is treated by one practitioner, with drugs such as analgesics and (occasionally) anxiolytics.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By type, the market is divided into:
- Neurostimulation Devices
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- Spinal Cord Stimulation (SCS) Devices
- Ablation Devices
- RF Ablation Devices
- Cryoablation Devices
- Analgesic Infusion Pumps
- Internal
- External
Based on mode of purchase, the market can be segmented into:
- OTC
- Prescription-Based
The market is divided based on application into:
- Neuropathic Pain
- Cancer Pain
- Facial Pain and Migraine
- Musculoskeletal Pain
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
High Prevalence of Diabetes to Bolster the Growth of the Pain Management Devices Market
With the increase in the number of diabetic patients, the demand for pain management devices is at an all-time high. A lot of patients have felt relief after using these devices. This has led to a growth of the pain management devices market. Additionally, neurostimulation devices like transcutaneous electrical nerve stimulation (TENS) devices have shown a lot of promise for pain relief for patients with neuropathic as well as spinal cord injury. This is further driving the growth of the pain management devices market.
Over the forecast period, increasing demand for OTC as well as TENS is expected to favour the market growth. The growing prevalence of lifestyle disorders and the rising cancer cases is expected to be a major trend in the coming years.
Key Players in the Global Pain Management Devices Market
The report gives a detailed analysis of the following key players in the global pain management devices market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Abbott Laboratories
- Becton, Dickinson and Company
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Johnson & Johnson Services, Inc
- Medtronic Plc
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Mode of Purchase |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Pain Management Devices Overview
3.1 Global Pain Management Devices Market Historical Value (2017-2023)
3.2 Global Pain Management Devices Market Forecast Value (2024-2032)
4 Global Pain Management Devices Landscape
4.1 Global Pain Management Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Pain Management Devices Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by End User
4.2.3 Analysis by Applications
5 Global Pain Management Devices Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Pain Management Devices Market Segmentation
6.1 Global Pain Management Devices Market by Type
6.1.1 Market Overview
6.1.2 Neurostimulation Devices
6.1.2.1 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
6.1.2.2 Spinal Cord Stimulation (SCS) Devices
6.1.3 Ablation Devices
6.1.3.1 RF Ablation Devices
6.1.3.2 Cryoablation Devices
6.1.4 Analgesic Infusion Pump
6.1.4.1 Internal
6.1.4.2 External
6.2 Global Pain Management Devices Market by Mode of Purchase
6.2.1 Market Overview
6.2.2 OTC
6.2.3 Prescription Based
6.3 Global Pain Management Devices Market by Application
6.3.1 Market Overview
6.3.2 Neuropathic Pain
6.3.3 Cancer Pain
6.3.4 Facial Pain and Migraine
6.3.5 Musculoskeletal Pain
6.3.6 Others
6.4 Global Pain Management Devices Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Clinics
6.4.4 Home healthcare
6.4.5 Ambulatory Surgical Centers
6.4.6 Laboratories & Research facilities
6.5 Global Pain Management Devices Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Pain Management Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Pain Management Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Pain Management Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Pain Management Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Pain Management Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Abbott Laboratories
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Becton, Dickinson and Company
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Boston Scientific Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 B. Braun Melsungen AG
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Johnson & Johnson Services, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Medtronic Plc
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Braun Melsungen AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Baxter
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Nevro Corp.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Enovis
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 OMRON Healthcare, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 ICU Medical, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Stryker Corporation
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Stimwave LLC
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
18 Global Pain Management Devices Market- Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The pain management devices market was valued at USD 5.22 billion in 2023.
The market is expected to grow at a CAGR of 8.7% from 2024 to 2032 to reach USD a value of USD 11.05 billion by 2032.
The market is primarily being driven by the increasing demand for OTC and TENS, presence of large population, rise in geriatric population, rising consumer disposable income, growing prevalence of lifestyle disorders, and the rising cancer cases.
The key trends propelling the market are the introduction of neurostimulation technologies, such as transcutaneous electrical nerve stimulation (TENS) devices, and an increase in the number of diabetic patients.
The major regions in the market are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific with the Asia Pacific accounting for the largest share in the market.
The neurostimulation devices sector is the dominant type in the market.
The OTC and prescription-based segments are the leading modes of purchase in the market.
The market is divided based on application into neuropathic pain, cancer pain, facial pain and migraine, and musculoskeletal pain, among others.
The major players in the market are Abbott Laboratories, Becton, Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Johnson & Johnson Services, Inc., and Medtronic Plc, among others.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER